Shrikant Anant
Overview
Explore the profile of Shrikant Anant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
4150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arnold L, Yap M, Farrokhian N, Jackson L, Barry M, Ly T, et al.
Mol Cancer
. 2025 Feb;
24(1):50.
PMID: 39994636
Background: HNSCC presents a significant health challenge due to its high mortality resulting from treatment resistance and locoregional invasion into critical structures in the head and neck region. Understanding the...
2.
Standing D, Dandawate P, Gunewardena S, Covarrubias-Zambrano O, Roby K, Khabele D, et al.
Cell Death Dis
. 2024 May;
15(5):362.
PMID: 38796478
Advanced epithelial ovarian cancer (EOC) survival rates are dishearteningly low, with ~25% surviving beyond 5 years. Evidence suggests that cancer stem cells contribute to acquired chemoresistance and tumor recurrence. Here,...
3.
Arnold L, Yap M, Jackson L, Barry M, Ly T, Morrison A, et al.
bioRxiv
. 2024 Apr;
PMID: 38645056
Head and neck squamous cell carcinoma (HNSCC) is a major health concern due to its high mortality from poor treatment responses and locoregional tumor invasion into life sustaining structures in...
4.
Hamel Z, Sanchez S, Standing D, Anant S
Explor Target Antitumor Ther
. 2024 Mar;
5(5):20-34.
PMID: 38464736
Pancreatic cancer remains a serious and deadly disease, impacting people globally. There remain prominent gaps in the current understanding of the disease, specifically regarding the role of the signal transducer...
5.
Arnold L, Gomez J, Barry M, Yap M, Jackson L, Ly T, et al.
Explor Target Antitumor Ther
. 2023 Nov;
4(5):1104-1121.
PMID: 38023989
Aim: Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with a survival rate below fifty percent. Addressing meager therapeutic options, a series of small...
6.
Standing D, Feess E, Kodiyalam S, Kuehn M, Hamel Z, Johnson J, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37173951
Ovarian cancer (OvCa) is a deadly gynecologic malignancy that presents many clinical challenges due to late-stage diagnoses and the development of acquired resistance to standard-of-care treatment protocols. There is an...
7.
Bhattacharyya S, Ghosh H, Covarrubias-Zambrano O, Jain K, Swamy K, Kasi A, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047307
Pancreatic ductal adenocarcinoma (PDAC) is the primary reason for cancer-related deaths in the US. Genetic mutations, drug resistance, the involvement of multiple signaling pathways, cancer stem cells (CSCs), and desmoplastic...
8.
Standing D, Dandawate P, Anant S
Front Endocrinol (Lausanne)
. 2023 Jan;
13:1112987.
PMID: 36714582
Prolactin (PRL) is a peptide hormone mainly secreted from the anterior pituitary gland. PRL is reported to play a role in pregnancy, mammary gland development, immune modulation, reproduction, and differentiation...
9.
Standing D, Arnold L, Dandawate P, Ottemann B, Snyder V, Ponnurangam S, et al.
Mol Carcinog
. 2022 Oct;
62(2):145-159.
PMID: 36218231
Doublecortin like kinase 1 (DCLK1) plays a crucial role in several cancers including colon and pancreatic adenocarcinomas. However, its role in squamous cell carcinoma (SCC) remains unknown. To this end,...
10.
Alalem M, Bhosale M, Ranjan A, Yamamoto S, Kaida A, Nishikawa S, et al.
Cancers (Basel)
. 2022 Sep;
14(17).
PMID: 36077724
Accumulation of missense mutant p53 (mutp53) in cancers promotes malignant progression. DNAJA1, a member of HSP40 (also known as J-domain proteins: JDPs), is shown to prevent misfolded or conformational mutp53...